Regulated information
Nazareth (Belgium)/Rotterdam (The Netherlands), 26 August 2022 – 8AM CET
Disclosure of received notification from The Goldman Sachs Group, Inc. and NN Group N.V.
Pursuant to the Belgian law of 2 May 2007 regarding the disclosure of major shareholdings in listed companies (the Law), Fagron received notifications from The Goldman Sachs Group, Inc. and NN Group N.V.
Notification from The Goldman Sachs Group, Inc.
Notification from NN Group
On the date of the Transaction, an investment management agreement between NN Group and NNIP as the Investment Manager, came into effect. On the same date, three powers of attorney relating to the asset management agreement also took effect as granted by NN Re (Netherlands) N.V., respectively Nationale-Nederlanden Schadeverzekering Maatschappij N.V. and Nationale-Nederlanden Levensverzekering Maatschappij N.V. (all members of the NN Group), to NNIP. These powers of attorney will terminate on the date that the asset management agreements terminate, or when NN Group upon its sole discretion decides to revoke the powers of attorney.
As a consequence, the voting rights referred to in heading 10A of the NN Group notification are held by NN Re (Netherlands) N.V., Nationale-Nederlanden Schadeverzekering Maatschappij N.V. and Nationale-Nederlanden Levensverzekering Maatschappij N.V., and are reported as linked to the securities, according to art. 7, 5° of the Law. Moreover, NNIP as the Investment Manager can, in the name of NN Group, exercise the voting rights attached to the shares at its discretion in the absence of specific instructions by NN Group, and within the following limitations: (i) NNIP must exercise the voting rights in a manner that is exclusively in the interest of NN Group, and in accordance with the voting policy of NN Group; and (ii) whereas NN Group can update its voting policy upon its own discretion, NNIP must ensure that it always exercises the voting rights in line with the latest version of the policy (and until the time that the new policy is being implemented, NN Group may give NNIP specific voting instructions).
NNIP as the Investment Manager, can exercise the voting rights referred to in heading 10A of the Goldman Sachs notification attached to the shares at its discretion in the absence of specific instructions. These voting rights are reported as not linked to the securities, according to art. 7, 5° of the Law. Moreover, the majority of the voting rights referred to in heading 10A of the Goldman Sachs notification is held by NN Re (Netherlands) N.V., Nationale-Nederlanden Schadeverzekering Maatschappij N.V. and Nationale-Nederlanden Levensverzekering Maatschappij N.V. and reported as linked to the securities in the NN Group notification, according to art. 7, 5° of the Law. However, the heading 10A of the Goldman Sachs notification also includes other voting rights which NNIP can exercise at its discretion, not associated with the positions managed for NN Group that are included in its notification.
Further information
Karen Berg
Global Investor Relations Manager
Tel. +31 6 53 44 91 99
karen.berg@fagron.com
About Fagron
Fagron is a leading global company active in pharmaceutical compounding, focusing on delivering personalized medicine to hospitals, pharmacies, clinics, and patients in 35 countries around the world.
Belgian company Fagron NV has its registered office in Nazareth and is listed on Euronext Brussels and Euronext Amsterdam under the ticker symbol ‘FAGR’. Fagron’s operational activities are managed by the Dutch company Fagron BV, which is headquartered in Rotterdam.
In the event of differences between the English translation and the Dutch original of this press release, the latter prevails.
Please open the link below for the press release:
Disclosure of received notification from The Goldman Sachs Group, Inc. and NN Group N.V.
TAIPEI, June 22, 2024 /PRNewswire/ -- The prestigious 2024 Tang Prize Laureates have been announced,…
Afrezza® Afrezza® (insulin human) Inhalation Powder. Study proves inhaled insulin is as effective as usual…
PURCHASE, NY, June 21, 2024 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader…
TERN-501 significantly improved the efficacy of a GLP-1 receptor agonist by normalizing energy expenditure, resulting…
MINNEAPOLIS, June 21, 2024 (GLOBE NEWSWIRE) -- Goodness Growth Holdings, Inc. ("Goodness Growth" or the…
Shrivers Hospice sets a benchmark for quality care in Ohio with prestigious award LOS ANGELES,…